Goal: Understand the clinical and economic burden of beta-thalassemia
The Challenge
The Challenge
The Challenge
Limited Data: The client needed real-world data on beta-thalassemia patients to inform their decision-making
The Solution
The Solution
The Solution
Retrospective Claims Study: Conducted a detailed analysis of Taiwan's National Health Insurance Research Database from 2001 to 2016.
Key Findings
The Solution
The Solution
Higher red blood cell transfusion (RBCT) burden was generally associated with a significantly higher prevalence of complications among patients with beta-thalassemia
Patients receiving higher numbers of RBCT units have a significantly increased burden of cardiac, endocrine, liver and renal complications
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.